Premium
An efflux inhibitor of the MacAB pump in Salmonella enterica serovar Typhimurium
Author(s) -
Yamagishi Ami,
Nakano Sohei,
Yamasaki Seiji,
Nishino Kunihiko
Publication year - 2020
Publication title -
microbiology and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 70
eISSN - 1348-0421
pISSN - 0385-5600
DOI - 10.1111/1348-0421.12765
Subject(s) - salmonella enterica , efflux , microbiology and biotechnology , salmonella , biology , multiple drug resistance , serotype , mutant , virulence , antibiotics , virology , bacteria , biochemistry , gene , genetics
Multidrug efflux pumps play an important role in bacterial multidrug resistance by actively excreting antibiotics. The ATP‐binding cassette–type drug efflux pump MacAB was originally reported as a macrolide‐specific pump. MacAB is also known to be required for the virulence of Salmonella enterica serovar Typhimurium following oral infection in mice. Here, we performed a screening of inhibitors of Salmonella MacAB and found a compound that increased the susceptibility of a MacAB‐expressing strain to macrolides. It was previously reported that MacAB is required to resist peroxide‐mediated killing in vitro and that a supernatant of wild‐type Salmonella rescues the growth defect of a macAB mutant in H 2 O 2 . In this study, we also found that the MacAB inhibitor reduced the ability of the supernatant to rescue Salmonella cells in H 2 O 2 . This compound could lead to a better understanding of the function of MacAB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom